tirzepatide
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Muscle-boosting drug could help retain lean tissue when using weight-loss jabs
The Independent's journalism is supported by our readers. When you purchase through links on our site, we may earn commission. Muscle-boosting drug could help retain lean tissue when using weight-loss jabs
The next goal for weight loss drugs? Fewer injections
For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It may be fewer injections. Pfizer and Amgen are developing monthly GLP-1 shots — a departure from injections like Wegovy and Zepbound, which are taken weekly.
Life-changing medicine or beauty hack? How Ozempic came to be seen as both, and why that's risky
Life-changing medicine or beauty hack? How Ozempic came to be seen as both, and why that's risky The same drug that is helping patients manage diabetes and reduce their risk of serious complications from chronic conditions is also being discussed as a beauty hack by people hoping to lose a few kilograms. Experts say more education and awareness are needed.
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm any anti-cancer benefit. A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than two dozen studies presented over the...
Weight loss drug maker sinks 25% after new safety data spooks investors
Shares of weight loss drug maker Zealand Pharma plummeted as much as 26% on Monday after new data on its experimental medicine raised concerns over its potential side effects. The Danish drugmaker said that while its drug survodutide met its key targets in a late-stage study, 19% of patients dropped out of the study due to gastrointestinal events, compared to 2.9% on placebo. "Safety/tolerability remains the key issue," said Barclays analysts in a note on Monday.
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk Popular GLP-1 weight-loss drugs may have an unexpected bonus: a significantly lower risk of breast cancer. - Date: - June 6, 2026 - Source: - University of Pennsylvania School of Medicine - Summary: - A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.
Comedian Bert Kreischer says blood clot scare may have saved him from dying in a tour bus fire
Comedian Bert Kreischer revealed how suffering a terrifying medical ordeal may have saved his life. In early January, the 53-year-old "Free Bert" star went to the emergency room after severe leg pain woke him up in the middle of the night. At the hospital, doctors found a significant blood clot behind Kreischer's knee and then discovered additional clots in his lungs.
Weight loss jabs 'should be probed as cancer prevention agents' after US study
Weight loss jabs 'should be probed as cancer prevention agents' after US study Scientists say a new study into weight loss drugs like Mounjaro, Wegovy and Ozempiccan suggest the impact of GLP-1 medicines "may reach further and transform how we think about cancer prevention" Weight loss jabs should be probed as potential "cancer prevention agents", experts say. A study has shown weight loss injections used to tackle obesity and type 2 diabetes - including Mounjaro, Wegovy and Ozempiccan - may...
Weight-loss jabs could slash cancer risk 41 per cent, experts say
Weight-loss jabs could slash cancer risk 41 per cent, experts say A major new study looks at thousands of people taking the medication Weight loss jabs could should be investigated as potential “cancer prevention agents”, experts have said after a study linked the medication to a reduced risk of cancers linked to obesity. Being overweight or obese has been linked to an increased risk of 13 types of cancer including of the breast, bowel, pancreas, kidney, liver and stomach. Glucagon-like...
Retatrutide: Triple acting jab for type 2 diabetes lowers blood sugar and boosts weight loss, trial reports
Retatrutide, a triple action treatment for type 2 diabetes, could significantly reduce blood glucose concentrations and body weight in patients with the condition, a phase 3 trial has reported. The results, published in the Lancet,1 show that patients who received injections of retatrutide for 40 weeks lost more than four times as much weight as those in the placebo group. After 40 weeks the average reduction in HbA1c with the new treatment was more than twice that in the placebo group,...